Pharmacokinetics and bioequivalence of Azithromycin Granules in healthy volunteers
Xiaomin Wan
Abstract
Xiaomin Wan
Abstract
Objective:To study the pharmacokinetics and bioequivalence of Azithromycin Granules in healthy volunteers. Methods:The plasma concentrations of azithromycin in 20 healthy male volunteers were determined by LC/MS/MS methods after being orally administered with single dose of 0.5 g Azithromycin Granules by randomized crossover way ; the pharmacokinetic parameters and the relative bioequivalence of the two preparations of azithromycin were calculated by DAS Ver 2.0 software. Results:The main pharmacokinetic parameters of azithromycin were as follows:Cmax were (537.4±168.2) ng/ml and (540.6±169.0) ng/ml;tmax were (2.0±0.7) h and (1.9±0.7) h;t1/2 were (31.3±11.6) h and (32.6±16.3) h;AUC0→72 were (4 736.7±2 408.9) ng.h/ml and(4 779.2±2 405.2) ng.h/ml; AUC0→∞ were (5 578.6±2 796.3) ng.h/ml and (5 635.6± 2 594.1) ng.h/ml for test preparation and reference preparation respectively. The 90% confindential interval of AUC0→72,AUC0→∞ and Cmax of test preparation were 93.2%-104.4%,91.8%-103.0% and 96.5%-102.2%,respectively. The relative bioavailability of azithromycin was (100.5±13.1)%. Conclusion:The results of the statistic analysis showes that Azithromycin Granules test preparation and reference preparation were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the pharmacokinetics and bioequivalence of Azithromycin Granules in healthy volunteers. Methods:The plasma concentrations of azithromycin in 20 healthy male volunteers were determined by LC/MS/MS methods after being orally administered with single dose of 0.5 g Azithromycin Granules by randomized crossover way ; the pharmacokinetic parameters and the relative bioequivalence of the two preparations of azithromycin were calculated by DAS Ver 2.0 software. Results:The main pharmacokinetic parameters of azithromycin were as follows:Cmax were (537.4±168.2) ng/ml and (540.6±169.0) ng/ml;tmax were (2.0±0.7) h and (1.9±0.7) h;t1/2 were (31.3±11.6) h and (32.6±16.3) h;AUC0→72 were (4 736.7±2 408.9) ng.h/ml and(4 779.2±2 405.2) ng.h/ml; AUC0→∞ were (5 578.6±2 796.3) ng.h/ml and (5 635.6± 2 594.1) ng.h/ml for test preparation and reference preparation respectively. The 90% confindential interval of AUC0→72,AUC0→∞ and Cmax of test preparation were 93.2%-104.4%,91.8%-103.0% and 96.5%-102.2%,respectively. The relative bioavailability of azithromycin was (100.5±13.1)%. Conclusion:The results of the statistic analysis showes that Azithromycin Granules test preparation and reference preparation were bioequivalent.
Key concepts: Bioequivalence, Azithromycin, Cmax, Pharmacokinetics, Medicine, Bioavailability, Crossover study, Pharmacology